Log in
Enquire now
Seaport Therapeutics

Seaport Therapeutics

Seaport Therapeutics operates as a clinical stage biopharmaceutical company.

OverviewStructured DataIssuesContributors
Is a
Organization
Organization
Company
Company
B2X
B2C
B2C
CEO
Daphne Zohar
Daphne Zohar
CMO
‌
Antony Loebel, M.D.
Crunchbase URL
crunchbase.com/organiz...apeutics
Email Address
info@seaporttx.com
publicrelations@seaporttx.com
Founder
Daphne Zohar
Daphne Zohar
Industry
Healthcare
Healthcare
Biotechnology
Biotechnology
Pharmaceutical industry
Pharmaceutical industry
Investors
Invus
Invus
Third Rock Ventures
Third Rock Ventures
ARCH Venture Partners
ARCH Venture Partners
Sofinnova Investments
Sofinnova Investments
‌
Goldman Sachs Alternatives
T. Rowe Price
T. Rowe Price
General Atlantic
General Atlantic
Latest Funding Round Date
October 21, 2024
Latest Funding Round Amount (USD)
225,000,000
Latest Funding Type
Series B
Series B
LinkedIn URL
@company/seaport-therapeutics
Location
Boston, Massachusetts, United States
Boston, Massachusetts, United States
Number of Employees (Ranges)
11 – 50
Total Funding Amount (USD)
225,000,000
Twitter URL
@SeaportTx
Official Website
seaporttx.com

Find more companies like Seaport Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.